Search research articles
Contact Us
Filters
Showing results (221-230 of 409) with videos related to
Page
of 41
Sort By:
Journal of Medicinal Chemistry
|
July 31, 1998
4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships
B Pirotte, T Podona, O Diouf, et al.
Blood
|
September 14, 2012
Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1
Christopher M Denis, Seth Chitayat, Michael J Plevin, et al.
Human Pathology
|
February 5, 2011
Differential expression of cell-cycle regulatory proteins defines distinct classes of follicular lymphoma
Abdulmohsen Alhejaily, Brianne Wood, Cheryl J Foster, et al.
Journal of Medicinal Chemistry
|
July 27, 2001
Original 2-alkylamino-6-halogenoquinazolin-4(3H)-ones and K(ATP) channel activity
F Somers, R Ouedraogo, M H Antoine, et al.
Journal of Chromatography. A
|
June 28, 2011
Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space
B Debrus, P Lebrun, J Mbinze Kindenge, et al.
Bioorganic & Medicinal Chemistry
|
September 11, 1999
Preparation and pharmacological evaluation of the R- and S-enantiomers of 3-(2-butylamino)-4H- and 3-(3-methyl-2-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openers
S Khelili, P de Tullio, P Lebrun, et al.
Journal of Chromatography. A
|
October 11, 2012
Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugs
J K Mbinze, P Lebrun, B Debrus, et al.
The Journal of Biological Chemistry
|
February 27, 2020
Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A
Marina R Lochhead, Alexandra D Brown, Alyssa C Kirlin, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships
P de Tullio, B Pirotte, P Lebrun, et al.
European Journal of Clinical Investigation
|
December 12, 2001
Surfing the insulin signaling web
E Van Obberghen, V Baron, L Delahaye, et al.
Page
of 41
Search research articles
Search
Showing results (221-230 of 409) with videos related to
Sort By:
Page
of 41
Journal of Medicinal Chemistry
|
July 31, 1998
4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships
B Pirotte, T Podona, O Diouf, et al.
Blood
|
September 14, 2012
Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1
Christopher M Denis, Seth Chitayat, Michael J Plevin, et al.
Human Pathology
|
February 5, 2011
Differential expression of cell-cycle regulatory proteins defines distinct classes of follicular lymphoma
Abdulmohsen Alhejaily, Brianne Wood, Cheryl J Foster, et al.
Journal of Medicinal Chemistry
|
July 27, 2001
Original 2-alkylamino-6-halogenoquinazolin-4(3H)-ones and K(ATP) channel activity
F Somers, R Ouedraogo, M H Antoine, et al.
Journal of Chromatography. A
|
June 28, 2011
Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space
B Debrus, P Lebrun, J Mbinze Kindenge, et al.
Bioorganic & Medicinal Chemistry
|
September 11, 1999
Preparation and pharmacological evaluation of the R- and S-enantiomers of 3-(2-butylamino)-4H- and 3-(3-methyl-2-butylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide, two tissue selective ATP-sensitive potassium channel openers
S Khelili, P de Tullio, P Lebrun, et al.
Journal of Chromatography. A
|
October 11, 2012
Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugs
J K Mbinze, P Lebrun, B Debrus, et al.
The Journal of Biological Chemistry
|
February 27, 2020
Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A
Marina R Lochhead, Alexandra D Brown, Alyssa C Kirlin, et al.
Journal of Medicinal Chemistry
|
February 16, 1996
3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships
P de Tullio, B Pirotte, P Lebrun, et al.
European Journal of Clinical Investigation
|
December 12, 2001
Surfing the insulin signaling web
E Van Obberghen, V Baron, L Delahaye, et al.
Page
of 41